Korian announces the acquisition of 5 Santé Group, a key player in the treatment of chronic diseases

 

Korian announces its acquisition of 5 Santé, a rapidly developing French group that specialises in the treatment of chronic diseases from Catherine Miffre, its founder, and investment fund Parquest Capital. 5 Santé, which has an excellent reputation in the rehabilitation of patients suffering from respiratory diseases, offers customised care pathways to patients who live at home and visit its clinics for pre-scheduled stays. The group owns six post-acute and rehabilitation care clinics located in the French regions of Auvergne-Rhône-Alpes and Occitanie.

Founder and CEO Catherine Miffre and her management are joining Korian’s teams to pursue the development of 5 Santé.

 

“We are pleased to welcome 5 Santé’s medical teams to the Group, together with its dedicated team of researchers whose unique expertise, strengthens our innovation capabilities for the development of future projects. With this acquisition, Korian moves a step further towards specialising its services, in order to offer personalised support, adapted to the patient’s needs in the areas where the Group operates.”, Nicolas Merigot, France Healthcare Division Executive VP.

 

“5 Santé Group’s incorporation into the Korian group will strengthen our expertise in the treatment of chronic diseases. It will also reinforce innovation as part of the concept developed by our researchers to allow its application to all chronic pathologies and to accelerate its progress towards a pathway approach dedicated to improving the quality of life of ourpatients.”, Catherine Miffre, CEO of 5 Santé Group.